➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Colorcon
Dow
AstraZeneca

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Selegiline - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for selegiline and what is the scope of patent protection?

Selegiline is the generic ingredient in four branded drugs marketed by Somerset, Apotex, Dava Pharms Inc, Lannett Co Inc, Rising, Bausch, Apotex Inc, Boscogen, Chartwell Molecules, Cosette, G And W Labs Inc, MLV, and Mylan, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for selegiline. One supplier is listed for this compound.

Drug Prices for selegiline

See drug prices for selegiline

Recent Clinical Trials for selegiline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OxfordN/A
University of South FloridaPhase 4
Mood and Anxiety Research, IncPhase 3

See all selegiline clinical trials

Medical Subject Heading (MeSH) Categories for selegiline

US Patents and Regulatory Information for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 RX Yes No   Start Trial   Start Trial   Start Trial
Lannett Co Inc SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075145-001 Sep 15, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Somerset ELDEPRYL selegiline hydrochloride CAPSULE;ORAL 020647-001 May 15, 1996 DISCN Yes No   Start Trial   Start Trial   Start Trial
Rising SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 206803-001 Apr 2, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074565-001 Aug 2, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Mallinckrodt
Medtronic
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.